Pennsylvania 2025-2026 Regular Session Status: Passed House Bipartisan · 15 D · 2 R cosponsors

HB 33 — An Act amending the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, in preliminary provisions, further providing for definitions; in practitioners, further providing for practitioner registration; in medical marijuana controls, further providing for electronic tracking and for laboratory; and, in Medical Marijuana Advisory Board, further providing for advisory board.

Last action — Referred to Law & Justice

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has passed the House. Introduced January 10, 2025. It now moves to the second chamber.

Next likely step: consideration and a floor vote in the Senate.

Odds of enactment

Moderate chance

Based on the sponsor, cosponsors, and committee posture, this bill has a moderate chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 74% · high confidence

  • Passed House

    Current position in the legislative process.

  • 17 sponsors

    1 primary, 16 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (15 D · 2 R) — cross-party backing.

  • Cleared a recorded vote

    Passed 4 recorded votes so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Bill Text

What changed in the latest version

465 added · 434 removed

Plain-language change summary

The latest version of Bill HB 33 includes a new definition for "corrective action," which is a measure taken by approved labs to address operational deficiencies. Additionally, there were changes in Section 2 regarding certain sections of the act being revised. These updates are important because they help ensure that laboratories involved in testing medical marijuana meet stringent operational standards and can effectively handle issues when they arise, ultimately promoting safety and reliability in product testing.

→
Previous
Latest
PRIOR PRINTER'S NO.
CORRECTIVE REPRINT PRIOR PRINTER'S NOS.
12 PRINTER'S NO.
12, 372 PRINTER'S NO.
372 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL Session of 2025 No.
441 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL Session of 2025 No.
establishing a medical marijuana research program;
establishing a medical marijuana research the Department of Education and the Department of Humanns, Services;
imposing duties on the Department of Corrections, the Department of Education and the Department of Human centers and for penalties and enforcement," in preliminary provisions, further providing for definitions;
and providing for academic clinical research centers and for penalties and enforcement," in preliminary provisions, further providing for definitions;
* * * "Approved laboratory." An independent laboratory approved by the department, in accordance with section 704, to identify, 20250HB0033PN0372 - 2 - collect, handle and conduct tests on medical marijuana samples from a grower/processor, as part of the quality assurance testing and on medical marijuana samples from the department.
* * * "Approved laboratory." An independent laboratory approved by the department, in accordance with section 704, to identify, 20250HB0033PN0441 - 2 - collect, handle and conduct tests on medical marijuana samples from a grower/processor, as part of the quality assurance testing and on medical marijuana samples from the department.
* * * "Independent laboratory." A laboratory that:
"CORRECTIVE ACTION." AN ACTION TAKEN BY AN APPROVED ◄ LABORATORY TO RESOLVE, AND PREVENT FROM RECURRENCE, A DEFICIENCY ◄ WITH THE LABORATORY OPERATIONS.
◄ * * * "Independent laboratory." A laboratory that:
SECTION 2.
20250HB0033PN0441 - 3 - SECTION 2.
20250HB0033PN0372 - 3 - * * * (D) DEPARTMENT AUTHORITY.--THE DEPARTMENT MAY PLACE ONE OR MORE CONDITIONS ON A PRACTITIONER FOR INCLUSION IN THE REGISTRY, INCLUDING:
* * * (D) DEPARTMENT AUTHORITY.--THE DEPARTMENT MAY PLACE ONE OR MORE CONDITIONS ON A PRACTITIONER FOR INCLUSION IN THE REGISTRY, INCLUDING:
* * * (c) Access.--[Information] Except as provided in section 704(p), information maintained in electronic tracking systems under subsection (a) shall be confidential and not subject to the act of February 14, 2008 (P.L.6, No.3), known as the Right- 20250HB0033PN0372 - 4 - to-Know Law.
* * * (c) Access.--[Information] Except as provided in section 20250HB0033PN0441 - 4 - 704(p), information maintained in electronic tracking systems under subsection (a) shall be confidential and not subject to the act of February 14, 2008 (P.L.6, No.3), known as the Right- to-Know Law.
(2) The stability testing is done at six-month intervals for the duration of the expiration date period as listed on the medical marijuana product and once within six months of the expiration date.] (c) Application and approval.-- (1) An independent laboratory may apply, in the form and manner prescribed by the department, for approval to test medical marijuana in accordance with the medical marijuana program.
(2) The stability testing is done at six-month intervals for the duration of the expiration date period as listed on the medical marijuana product and once within six months of the expiration date.] (c) Application and approval.-- (1) An independent laboratory may apply, in the form and 20250HB0033PN0441 - 5 - manner prescribed by the department, for approval to test medical marijuana in accordance with the medical marijuana program.
20250HB0033PN0372 - 5 - (2) A nonrefundable initial application fee in the amount of $250 shall be paid by certified check or money order.
(2) A nonrefundable initial application fee in the amount of $250 shall be paid by certified check or money order.
(2) The department shall establish uniform medical marijuana testing standards and require that the approved laboratories report testing results in a manner as the department shall determine, including:
(2) The department shall establish uniform medical 20250HB0033PN0441 - 6 - marijuana testing standards and require that the approved laboratories report testing results in a manner as the department shall determine, including:
20250HB0033PN0372 - 6 - (i) Requiring a test at harvest and at final processing.
(i) Requiring a test at harvest and at final processing.
Research and development testing shall not be a replacement for any other testing required under this section.
20250HB0033PN0441 - 7 - Research and development testing shall not be a replacement for any other testing required under this section.
(g) Audit testing.--The department, in its sole discretion, 20250HB0033PN0372 - 7 - may conduct audit testing of medical marijuana samples collected from a grower/processor facility and medical marijuana products found at a dispensary facility using a cooperative laboratory or approved laboratory to identify, collect, handle and test the medical marijuana on the department's behalf.
(g) Audit testing.--The department, in its sole discretion, may conduct audit testing of medical marijuana samples collected from a grower/processor facility and medical marijuana products found at a dispensary facility using a cooperative laboratory or approved laboratory to identify, collect, handle and test the medical marijuana on the department's behalf.
(h) Standard operating procedures.-- (1) An approved laboratory shall maintain written standard operating procedures for all quality control sampling and testing procedures, including compliance testing, stability testing, research and development testing and quality assurance testing.
ALL SAMPLES TESTED ◄ BY THE DEPARTMENT, BY AN APPROVED LABORATORY OR COOPERATIVE ◄ LABORATORY MUST BE DE-IDENTIFIED AND ANONYMOUS.
THE AUDIT ◄ LABORATORY MAY NOT KNOW THE APPROVED LABORATORIES THAT HAVE ◄ TESTED THE SAMPLE, THE GROWER/PROCESSOR OR DISPENSARY FROM WHICH ◄ THE SAMPLE ORIGINATED AND THE TESTING HISTORY.
◄ (h) Standard operating procedures.-- (1) An approved laboratory shall maintain written standard operating procedures for all quality control sampling and testing procedures, including compliance testing, stability testing, research and development testing and quality assurance testing.
(4) An approved laboratory shall notify the department in writing of any modifications to its standard operating procedures no less than 30 days prior to the modification.
(4) An approved laboratory shall notify the department in writing of any modifications to its standard operating procedures no less than 30 15 BUSINESS days prior to the ◄ modification IMPLEMENTATION.
(i) Enforcement procedures.--The department shall conduct announced or unannounced inspections or investigations to determine an approved laboratory's compliance with its standard operating procedures and this act.
◄ 20250HB0033PN0441 - 8 - (i) Enforcement procedures.--The department shall conduct announced or unannounced inspections or investigations to determine an approved laboratory's compliance with its standard operating procedures and this act OR A REGULATION PROMULGATED ◄ UNDER THIS ACT.
The department may require the approved laboratory to submit and adhere to a corrective action plan following an inspection.
The department may require the approved ◄ laboratory to submit and adhere to a corrective action plan following an inspection.
20250HB0033PN0372 - 8 - (k) Quality assurance testing.-- (1) The department shall coordinate testing for quality assurance purposes related to the department and compliance by each approved laboratory no less than once a year beginning January 1 after the effective date of this paragraph.
(k) Quality assurance testing.-- (1) The department shall coordinate testing for quality assurance purposes related to the department and compliance by each approved laboratory no less than once a year beginning January 1 after the effective date of this paragraph.
(6) Nothing in this section shall be construed to prohibit the department from coordinating quality assurance testing more than once within a calendar year.
20250HB0033PN0441 - 9 - (6) Nothing in this section shall be construed to prohibit the department from coordinating quality assurance testing more than once within a calendar year.
(7) If the department determines that an approved laboratory's test results are unsatisfactory, the department shall initiate an investigation which may include the following:
(7) THE DETERMINATION OF "SATISFACTORY" OR ◄ "UNSATISFACTORY" SHALL BE BASED ON PREESTABLISHED CRITERIA ◄ PROVIDED BY THE DEPARTMENT.
◄ (7) (8) If the department determines that an approved ◄ laboratory's test results are unsatisfactory, the department shall initiate an investigation which may include the following:
(ii) A review of the approved laboratory's standard 20250HB0033PN0372 - 9 - operating procedures.
(ii) A review of the approved laboratory's standard operating procedures.
(3) The department shall approve or deny a revised corrective action plan within 30 days of receipt of the plan.
(3) The department shall approve or deny a revised 20250HB0033PN0441 - 10 - corrective action plan within 30 days of receipt of the plan.
20250HB0033PN0372 - 10 - (1) Failure to comply with the department as part of an inspection or investigation.
(1) Failure to comply with the department as part of an inspection or investigation.
(4) Failure to participate in the required quality assurance testing.
(4) Failure to participate in the required quality ◄ assurance OR AUDIT testing.
(5) Failure to produce:
◄ (5) Failure to produce:
(1) Revoke or suspend the approval to test medical marijuana of an approved laboratory found to be in violation of this act or a regulation promulgated under this act.
(1) Revoke or suspend the approval to test medical ◄ 20250HB0033PN0441 - 11 - marijuana of an approved laboratory found to be in violation ◄ of this act or a regulation promulgated under this act.
(2) Revoke or suspend the approval to test medical marijuana of an approved laboratory found to be in violation of an order issued under this act or a regulation promulgated under this act.
◄ (2) Revoke or suspend the approval to test medical ◄ marijuana of an approved laboratory found to be in violation ◄ of an order issued under this act or a regulation promulgated ◄ under this act.
(3) Revoke or suspend the approval to test medical marijuana of an approved laboratory for conduct or activity which would have disqualified the approved laboratory from receiving approval to test medical marijuana.
◄ (3) Revoke or suspend the approval to test medical ◄ marijuana of an approved laboratory for conduct or activity ◄ which would have disqualified the approved laboratory from ◄ receiving approval to test medical marijuana.
(4) Suspend an approved laboratory pending the outcome of a hearing in a case in which the approval to test medical marijuana could be revoked.
◄ (4) Suspend an approved laboratory pending the outcome ◄ of a hearing in a case in which the approval to test medical ◄ marijuana could be revoked.
20250HB0033PN0372 - 11 - (5) Order the approved laboratory to cease and desist testing medical marijuana.
◄ (5) Order the approved laboratory to cease and desist ◄ testing medical marijuana.
(p) Testing data and trend analysis.-- (1) An owner or operator of each approved laboratory shall ensure that the laboratory enters all of the following testing results into the seed-to-sale tracking system:
◄ (1) ORDER THE APPROVED LABORATORY TO CEASE AND DESIST ◄ TESTING MEDICAL MARIJUANA TO PROTECT THE PUBLIC'S HEALTH, ◄ SAFETY AND WELFARE.
◄ (2) REVOKE OR SUSPEND THE APPROVAL TO TEST MEDICAL ◄ MARIJUANA OF AN APPROVED LABORATORY FOR ANY OF THE FOLLOWING ◄ REASONS:
◄ (I) THE APPROVED LABORATORY IS FOUND TO BE IN ◄ VIOLATION OF THIS ACT OR A REGULATION PROMULGATED UNDER ◄ THIS ACT.
Show all 55 changed rows (15 more)
Previous
Latest
◄ (II) THE APPROVED LABORATORY HAS FAILED TO COMPLETE ◄ A CORRECTIVE ACTION PLAN.
◄ (III) FRAUDULENT REPORTING OF LABORATORY TEST ◄ RESULTS.
◄ (IV) FALSIFYING RECORDS AND LABORATORY DATA.
◄ (V) REPEATED FAILURES TO ADHERE TO STANDARD ◄ 20250HB0033PN0441 - 12 - OPERATING PROCEDURES.
◄ (p) Testing data and trend analysis.-- (1) An owner or operator of each approved laboratory shall ensure that the laboratory enters all of the following testing results into the seed-to-sale tracking system:
(vi) Compile and aggregate testing information to post on the department's publicly accessible Internet website.
(vi) Compile and aggregate DE-IDENTIFIED testing ◄ information to post on the department's publicly accessible Internet website.
The department shall provide an approved laboratory reasonable time to receive any additional accreditation beyond 20250HB0033PN0372 - 12 - the laboratory's most recent certificate of accreditation.
The department shall provide an approved laboratory reasonable time to receive any additional accreditation beyond the laboratory's most recent certificate of accreditation.
(r) State testing laboratory.--The department may establish and maintain a State testing laboratory.
20250HB0033PN0441 - 13 - (r) State testing laboratory.--The department may establish and maintain a State testing laboratory.
(i) In order to facilitate the prompt implementation of this section, the department shall have the authority 20250HB0033PN0372 - 13 - to promulgate temporary regulations which shall expire not later than two years following the publication of the temporary regulations in the Pennsylvania Bulletin under subparagraph (iii) and on the department's publicly accessible Internet website.
(i) In order to facilitate the prompt implementation of this section, the department shall have the authority to promulgate temporary regulations which shall expire 20250HB0033PN0441 - 14 - not later than two years following the publication of the temporary regulations in the Pennsylvania Bulletin under subparagraph (iii) and on the department's publicly accessible Internet website.
20250HB0033PN0372 - 14 - (3) Within 90 days of submitting the temporary regulations to the Legislative Reference Bureau, the department shall issue guidance to accompany the temporary regulations.
(3) Within 90 days of submitting the temporary 20250HB0033PN0441 - 15 - regulations to the Legislative Reference Bureau, the department shall issue guidance to accompany the temporary regulations.
A vote of the majority of the members present shall be sufficient for all actions of the advisory board unless the 20250HB0033PN0372 - 15 - bylaws require a greater number.
A vote of the majority of the members present shall be sufficient for all actions of the advisory board unless the bylaws require a greater number.
(e) Attendance.--A member of the advisory board appointed under subsection (a)(8) [or], (9) or (10) who fails to attend three consecutive meetings shall forfeit his seat unless the secretary, upon written request from the member, finds that the member should be excused from a meeting for good cause.
20250HB0033PN0441 - 16 - (e) Attendance.--A member of the advisory board appointed under subsection (a)(8) [or], (9) or (10) who fails to attend three consecutive meetings shall forfeit his seat unless the secretary, upon written request from the member, finds that the member should be excused from a meeting for good cause.
<-- 20250HB0033PN0372 - 16 - SECTION 5.
<-- SECTION 5.
<-- (1) THE ADDITION OF SECTION 401(D) OF THE ACT SHALL TAKE EFFECT IN 60 DAYS.
<-- 20250HB0033PN0441 - 17 - (1) THE ADDITION OF SECTION 401(D) OF THE ACT SHALL TAKE EFFECT IN 60 DAYS.
20250HB0033PN0372 - 17 -
20250HB0033PN0441 - 18 -
⬇ Download PDF
View plain text versions (3)

Action History

  1. Referred to Law & Justice

  2. Third consideration and final passage

  3. Re-reported as committed

  4. Re-committed to Appropriations

  5. Second consideration

  6. Removed from table

  7. Corrective Reprint, Printer's No. 441

  8. Laid on the table

  9. First consideration

  10. Reported as amended

  11. Referred to Health

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 16 co-sponsors · 236 not signed on · 8 voted No

Sponsors (1)

Co-sponsors (16)

Not signed on (236)

236 members have not signed on to this bill.

Show all 236 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Committee vote (Appropriations): Re-report Bill As Committed

Passed 37 Yea · 0 Nay
Party YeaNayPresentNot Voting
Democratic 21000
Unaffiliated 2000
Republican 14000
Total 37000
% of votes cast 100%0%0%0%
How each member voted (37)
Member Party Vote
Joshua Siegel — Yea
Torren Ecker — Yea
Abigail Salisbury Democratic Yea
Aerion Abney Democratic Yea
Anthony A. Bellmon Democratic Yea
Ben Waxman Democratic Yea
Benjamin V. Sanchez Democratic Yea
Bridget M. Kosierowski Democratic Yea
Dave Madsen Democratic Yea
Emily Kinkead Democratic Yea
Gina H. Curry Democratic Yea
Joe Webster Democratic Yea
Jordan A. Harris Democratic Yea
Justin C. Fleming Democratic Yea
Kyle J. Mullins Democratic Yea
La'Tasha D. Mayes Democratic Yea
Manuel Guzman Democratic Yea
Pat Gallagher Democratic Yea
Paul Friel Democratic Yea
Regina G. Young Democratic Yea
Steven R. Malagari Democratic Yea
Tarik Khan Democratic Yea
Tim Brennan Democratic Yea
Ann Flood Republican Yea
Charity Grimm Krupa Republican Yea
Eric Davanzo Republican Yea
Eric R. Nelson Republican Yea
James B. Struzzi Republican Yea
Jamie Barton Republican Yea
Jeff Olsommer Republican Yea
Joshua D. Kail Republican Yea
Kristin Marcell Republican Yea
Marci Mustello Republican Yea
Marla Brown Republican Yea
Ryan Warner Republican Yea
Thomas H. Kutz Republican Yea
Zachary Mako Republican Yea

Official roll call →

FINAL PASSAGE

Passed 194 Yea · 8 Nay
Party YeaNayPresentNot Voting
Democratic 99000
Republican 89800
Unaffiliated 6000
Total 194800
% of votes cast 96%4%0%0%
How each member voted (202)
Member Party Vote
Torren Ecker — Yea
Seth Grove — Yea
Dan Miller — Yea
Louis Schmitt — Yea
Stephenie Scialabba — Yea
Joshua Siegel — Yea
Abigail Salisbury Democratic Yea
Aerion Abney Democratic Yea
Amen Brown Democratic Yea
Andre D. Carroll Democratic Yea
Anita Astorino Kulik Democratic Yea
Anthony A. Bellmon Democratic Yea
Arvind Venkat Democratic Yea
Ben Waxman Democratic Yea
Benjamin V. Sanchez Democratic Yea
Brandon J. Markosek Democratic Yea
Brian Munroe Democratic Yea
Bridget M. Kosierowski Democratic Yea
Carol Hill-Evans Democratic Yea
Carol Kazeem Democratic Yea
Chris Pielli Democratic Yea
Christina D. Sappey Democratic Yea
Christopher M. Rabb Democratic Yea
Dan Frankel Democratic Yea
Dan K. Williams Democratic Yea
Daniel J. Deasy Democratic Yea
Danielle Friel Otten Democratic Yea
Danilo Burgos Democratic Yea
Darisha K. Parker Democratic Yea
Dave Madsen Democratic Yea
David M. Delloso Democratic Yea
Ed Neilson Democratic Yea
Eddie Day Pashinski Democratic Yea
Elizabeth Fiedler Democratic Yea
Emily Kinkead Democratic Yea
Frank Burns Democratic Yea
G. Roni Green Democratic Yea
Gina H. Curry Democratic Yea
Greg Scott Democratic Yea
Greg Vitali Democratic Yea
Heather Boyd Democratic Yea
Ismail Smith-Wade-El Democratic Yea
Jacklyn Rusnock Democratic Yea
Jared G. Solomon Democratic Yea
Jason Dawkins Democratic Yea
Jeanne McNeill Democratic Yea
Jennifer O'Mara Democratic Yea
Jessica Benham Democratic Yea
Jim Haddock Democratic Yea
Jim Prokopiak Democratic Yea
Joanna E. McClinton Democratic Yea
Joe Ciresi Democratic Yea
Joe McAndrew Democratic Yea
Joe Webster Democratic Yea
Johanny Cepeda-Freytiz Democratic Yea
John C. Inglis III Democratic Yea
Jordan A. Harris Democratic Yea
Jose Giral Democratic Yea
Joseph C. Hohenstein Democratic Yea
Justin C. Fleming Democratic Yea
Keith S. Harris Democratic Yea
Kristine C. Howard Democratic Yea
Kyle Donahue Democratic Yea
Kyle J. Mullins Democratic Yea
La'Tasha D. Mayes Democratic Yea
Leanne Krueger Democratic Yea
Lindsay Powell Democratic Yea
Lisa A. Borowski Democratic Yea
Liz Hanbidge Democratic Yea
Malcolm Kenyatta Democratic Yea
Mandy Steele Democratic Yea
Manuel Guzman Democratic Yea
Mary Jo Daley Democratic Yea
MaryLouise Isaacson Democratic Yea
Matthew D. Bradford Democratic Yea
Maureen E. Madden Democratic Yea
Melissa Cerrato Democratic Yea
Melissa L. Shusterman Democratic Yea
Michael H. Schlossberg Democratic Yea
Morgan Cephas Democratic Yea
Nancy Guenst Democratic Yea
Napoleon J. Nelson Democratic Yea
Nathan Davidson Democratic Yea
Nikki Rivera Democratic Yea
Pat Gallagher Democratic Yea
Patrick J. Harkins Democratic Yea
Paul Friel Democratic Yea
Paul Takac Democratic Yea
Perry S. Warren Democratic Yea
Peter Schweyer Democratic Yea
Regina G. Young Democratic Yea
Rick Krajewski Democratic Yea
Robert E. Merski Democratic Yea
Robert F. Matzie Democratic Yea
Robert Freeman Democratic Yea
Ryan A. Bizzarro Democratic Yea
Scott Conklin Democratic Yea
Sean Dougherty Democratic Yea
Steve Samuelson Democratic Yea
Steven R. Malagari Democratic Yea
Tarah Probst Democratic Yea
Tarik Khan Democratic Yea
Tim Brennan Democratic Yea
Tim Briggs Democratic Yea
Tina M. Davis Democratic Yea
Aaron Bernstine Republican Yea
Abby Major Republican Yea
Alec J. Ryncavage Republican Yea
Andrew Kuzma Republican Yea
Ann Flood Republican Yea
Barbara Gleim Republican Yea
Brad Roae Republican Yea
Brenda M. Pugh Republican Yea
Brett R. Miller Republican Yea
Brian C. Rasel Republican Yea
Brian Smith Republican Yea
Bryan Cutler Republican Yea
Bud Cook Republican Yea
Carl Walker Metzgar Republican Nay
Chad G. Reichard Republican Yea
Charity Grimm Krupa Republican Yea
Clint Owlett Republican Yea
Craig T. Staats Republican Yea
Craig Williams Republican Yea
Dallas Kephart Republican Yea
Dan Moul Republican Yea
Dane Watro Republican Yea
David H. Rowe Republican Yea
David H. Zimmerman Republican Yea
David M. Maloney Republican Yea
Donna Scheuren Republican Yea
Doyle Heffley Republican Yea
Eric Davanzo Republican Yea
Eric J. Weaknecht Republican Yea
Eric R. Nelson Republican Yea
Gary W. Day Republican Nay
Jack Rader Republican Yea
Jacob D. Banta Republican Yea
James B. Struzzi Republican Yea
Jamie Barton Republican Yea
Jamie L. Flick Republican Yea
Jamie Walsh Republican Yea
Jason Ortitay Republican Yea
Jeff Olsommer Republican Yea
Jeremy Shaffer Republican Yea
Jesse Topper Republican Yea
Jill N. Cooper Republican Yea
Jim Rigby Republican Yea
Joanne Stehr Republican Yea
Joe Emrick Republican Yea
Joe Hamm Republican Yea
Joe Hogan Republican Yea
Joe Kerwin Republican Yea
John A. Lawrence Republican Yea
John A. Schlegel Republican Yea
Jonathan Fritz Republican Yea
Joseph D'Orsie Republican Yea
Josh Bashline Republican Yea
Joshua D. Kail Republican Yea
Kate A. Klunk Republican Yea
Kathleen C. Tomlinson Republican Yea
Kathy L. Rapp Republican Yea
Keith J. Greiner Republican Yea
Kerry A. Benninghoff Republican Yea
Kristin Marcell Republican Yea
Leslie Rossi Republican Yea
Marc S. Anderson Republican Yea
Marci Mustello Republican Yea
Mark M. Gillen Republican Yea
Marla Brown Republican Yea
Martin T. Causer Republican Yea
Martina A. White Republican Yea
Michael Stender Republican Yea
Mike Armanini Republican Yea
Mike Jones Republican Yea
Milou Mackenzie Republican Yea
Mindy Fee Republican Yea
Natalie Mihalek Republican Yea
Parke Wentling Republican Nay
Perry A. Stambaugh Republican Nay
R. Lee James Republican Yea
Rich Irvin Republican Nay
Rob W. Kauffman Republican Yea
Robert Leadbeter Republican Yea
Roman Kozak Republican Yea
Russ Diamond Republican Yea
Ryan Warner Republican Nay
Scott Barger Republican Yea
Shelby Labs Republican Yea
Sheryl M. Delozier Republican Yea
Stephanie Borowicz Republican Nay
Steven C. Mentzer Republican Yea
Thomas H. Kutz Republican Yea
Thomas L. Mehaffie Republican Yea
Tim Twardzik Republican Yea
Timothy J. O'Neal Republican Yea
Timothy R. Bonner Republican Yea
Tina Pickett Republican Yea
Tom Jones Republican Yea
Valerie S. Gaydos Republican Yea
Wendy Fink Republican Nay
Zachary Mako Republican Yea

Official roll call →

Committee vote (Health): Adopt Amendment

Passed 25 Yea · 1 Nay
Party YeaNayPresentNot Voting
Democratic 14000
Republican 11100
Total 25100
% of votes cast 96%4%0%0%
How each member voted (26)
Member Party Vote
Arvind Venkat Democratic Yea
Benjamin V. Sanchez Democratic Yea
Bridget M. Kosierowski Democratic Yea
Dan Frankel Democratic Yea
Danielle Friel Otten Democratic Yea
Heather Boyd Democratic Yea
Jessica Benham Democratic Yea
Kristine C. Howard Democratic Yea
La'Tasha D. Mayes Democratic Yea
Lisa A. Borowski Democratic Yea
Liz Hanbidge Democratic Yea
Melissa L. Shusterman Democratic Yea
Rick Krajewski Democratic Yea
Tarik Khan Democratic Yea
Brad Roae Republican Yea
Charity Grimm Krupa Republican Yea
David H. Zimmerman Republican Yea
Gary W. Day Republican Yea
Jamie Walsh Republican Yea
Joanne Stehr Republican Yea
Kathy L. Rapp Republican Yea
Leslie Rossi Republican Yea
Marla Brown Republican Yea
Stephanie Borowicz Republican Nay
Tim Twardzik Republican Yea
Timothy R. Bonner Republican Yea

Official roll call →

Committee vote (Health): Report Bill As Amended

Passed 25 Yea · 1 Nay
Party YeaNayPresentNot Voting
Democratic 14000
Republican 11100
Total 25100
% of votes cast 96%4%0%0%
How each member voted (26)
Member Party Vote
Arvind Venkat Democratic Yea
Benjamin V. Sanchez Democratic Yea
Bridget M. Kosierowski Democratic Yea
Dan Frankel Democratic Yea
Danielle Friel Otten Democratic Yea
Heather Boyd Democratic Yea
Jessica Benham Democratic Yea
Kristine C. Howard Democratic Yea
La'Tasha D. Mayes Democratic Yea
Lisa A. Borowski Democratic Yea
Liz Hanbidge Democratic Yea
Melissa L. Shusterman Democratic Yea
Rick Krajewski Democratic Yea
Tarik Khan Democratic Yea
Brad Roae Republican Yea
Charity Grimm Krupa Republican Yea
David H. Zimmerman Republican Yea
Gary W. Day Republican Yea
Jamie Walsh Republican Yea
Joanne Stehr Republican Yea
Kathy L. Rapp Republican Yea
Leslie Rossi Republican Yea
Marla Brown Republican Yea
Stephanie Borowicz Republican Nay
Tim Twardzik Republican Yea
Timothy R. Bonner Republican Yea

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors HB 33?
HB 33 is sponsored by Dan Frankel (Democratic), Chris Pielli (Democratic), Jose Giral (Democratic), Tarik Khan (Democratic), Carol Hill-Evans (Democratic), Kristine C. Howard (Democratic), Benjamin V. Sanchez (Democratic), Joe Ciresi (Democratic), Tim Twardzik (Republican), G. Roni Green (Democratic), Dan K. Williams (Democratic), Tina M. Davis (Democratic), Justin C. Fleming (Democratic), Dave Madsen (Democratic), Keith S. Harris (Democratic), Kathy L. Rapp (Republican), and Liz Hanbidge (Democratic).
What is the current status of HB 33?
This bill has passed the House. Introduced January 10, 2025. It now moves to the second chamber.
Where can I track HB 33?
Track HB 33 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 33

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 33

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →